09-18 Novartis' Cosentyx Gets EU Medicines Agency Panel Recommendation for Polymyalgia Rheumatica MT
09-18 Novartis receives positive CHMP opinion for Cosentyx(R) in polymyalgia rheumatica (PMR) DJ
09-18 Swiss government concerned about Kremlin seizure of Nestle business in Russia RE
09-18 AlphaValue/Baader Europe Upgrades UBS to Add, Lifts PT MT
09-18 Oppenheimer Adjusts Price Target on Amrize to $55 From $62, Keeps Outperform Rating MT
09-18 Indian Food Regulator Takes Legal Action Against Nestlé Unit Over Infant Nutrition Product Claims MT
09-18 Advanz Pharma's Allergic Asthma Biosimilar Adcomfo Recommended for EU Approval MT
09-18 EU Medicines Agency Panel Backs Approval of Biocon Biologics Ireland's Breast Cancer Biosimilar MT
09-18 Roche's Multiple Sclerosis Drug Ocrevus Recommended for EU Approval MT
09-18 Anthropic quietly sets up biology lab as it ramps AI drug program RE
09-18 Kremlin says action on Nestlé and Auchan assets was taken because they're from 'unfriendly' states RE
09-18 Partners Group Private Equity, Aboria Capital buy UK student housing AN
09-18 Indian Food Regulator Takes Legal Action Against Nestlé Unit Over Infant Nutrition Product Claims MT
09-18 Yum! Brand's Pizza Hut Pursues $1.5 Billion Bond Sale for Buyout MT
09-18 Nestlé Weighs Options After Russia Places Units Under Administration MT
09-18 India finds Nestle baby food sample substandard, takes legal action RE
09-18 Nestle Weighs Options for Russia Unit After Moscow Seizes Control -- Update DJ
09-18 Nestle responds to its Russian operations being placed under temporary administration Zonebourse
09-18 Nestlé Reviews Options After Russia Places Business Under Temporary Administration MT
09-18 Nestle Weighs Options for Russia Unit After Moscow Puts It Under Administration DJ
09-18 Nestle : Update on Nestlé's operations in Russia DJ
09-18 Swiss stocks - Factors to watch on September 18 RE
09-18 Putin Signs Decree to Temporarily Seize Nestlé Assets in Russia MT
09-17 UBS Chairman says AT1 capital proposal is an acceptable compromise RE
09-17 Swiss Upper House Delays Vote on New UBS Capital Requirements MT
09-17 UBS Capital Vote Delayed to Sept. 23 as Swiss Lawmakers Debate up to $20 Billion Requirement MT
09-17 UBS chairman warns bank could rethink Swiss base if rules too harsh RE
09-17 Swiss upper house ends Thursday's debate on UBS rules without voting RE
09-17 Swiss lawmaker withdraws motion to send bank bill back to government RE
09-17 Swiss trade surplus at CHF 3.79 bln in August RE
09-17 Roche's Late-stage Study for Follicular Lymphoma Therapy Meets Primary Endpoint MT
09-17 Swiss stocks - Factors to watch on September 17 RE
09-16 Novartis halts ALS drug development after mid-stage trial failure RE
09-16 Novartis Halts ALS Drug Development After Phase 2 Trial Miss MT
09-16 Novartis to End ALS Trial Amid String of Study Failures DJ
09-16 Novartis Discontinues Study for Investigational ALS Drug After Missing Endpoints MT
09-16 Novartis experimental drug for ALS fails, Bloomberg News reports RE
09-16 Swiss Re: Increase in Population, Assets Raises Risk of Higher Insured Natural Catastrophe Losses MT
09-16 UBS capital rules face further Swiss parliamentary hurdle RE
09-15 UBS could make big savings from Swiss AT1 capital proposal, investors say RE
No results match your criteria
  1. Stock Market
  2. Indices
  3. SMI
  4. News SMI
  5. News of the index components
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!